Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid

Toxicology
Jaya ChilakapatiKirk Kitchin

Abstract

Lung is a major target for arsenic carcinogenesis in humans by both oral and inhalation routes. However, the carcinogenic mode of action of arsenicals is unknown. We investigated the effects of inorganic arsenic (iAsIII), monomethylarsonous acid (MMAIII), dimethylarsinous acid (DMAIII) and dimethylthioarsinic acid (DMTA), a sulfur containing dimethyl arsenic metabolite, in human bronchial epithelial (BEAS-2B) cells. Cells were exposed to 3, 15 microM-iAsIII; 0.3, 1 microM-MMAIII; 0.2, 1 microM-DMAIII; 0.2, 0.9 microM-DMTA as non-cytotoxic and minimally cytotoxic ( approximately 20%) concentrations based on Neutral Red uptake assays after 24h of culture. Total RNA was isolated and gene expression analysis conducted using Affymetrix Human Genome 133 Plus 2.0 arrays. Differentially expressed genes (DEGs) were determined using a one-way ANOVA (p < or =0.05) by Rosetta Resolver, a Benjamini-Hochberg FDR (false discovery rate) multiple testing correction (< 0.05) followed by a Scheffe's post hoc test. For all compounds except DMTA, > 90% of DEG altered in the low concentration were also changed at the high concentration. There was a clear dose-response seen in the number of DEGs for all four compounds. iAsIII showed the highest numbe...Continue Reading

References

Jul 1, 1992·Environmental Health Perspectives·A H SmithM T Smith
Jun 21, 1989·Journal of the National Cancer Institute·R R ReddelC C Harris
Dec 6, 1996·Science·C J Sherr
Jan 22, 1998·Mutation Research·A M SalazarE Rojas
Oct 24, 1998·Biochemical and Biophysical Research Communications·D B MenzelR N Roth
Feb 24, 1999·Molecular Carcinogenesis·M L Rodriguez-PueblaC J Conti
Sep 24, 1999·Biochemical and Biophysical Research Communications·H K HamadehD B Menzel
Apr 17, 2001·Chemical Research in Toxicology·M J MassA D Kligerman
Oct 17, 2001·Toxicology and Applied Pharmacology·D J ThomasS Lin
Jan 5, 2002·Environmental Health Perspectives·G Stöhrer
Jun 22, 2002·Toxicology Letters·Sarfaraz AhmadWilliam R Cullen
May 3, 2003·Cancer Cell·Hugh Cam, Brian David Dynlacht
Aug 20, 2003·Chemical Research in Toxicology·Paul AndrewesKathleen Wallace
Mar 18, 2004·Journal of the National Cancer Institute·Michael P WaalkesBhalchandra A Diwan
Jul 28, 2004·Toxicology and Applied Pharmacology·Koichi KurodaGinji Endo
Aug 12, 2005·The Biochemical Journal·Jian WangKostas Pantopoulos
Nov 4, 2006·Biological Chemistry·Regina Brigelius-Flohé
Dec 6, 2006·Drug Metabolism Reviews·R Clark Lantz, Allison M Hays
Feb 6, 2007·Toxicology and Applied Pharmacology·Reingard RamlKevin A Francesconi
Mar 24, 2007·Toxicology and Applied Pharmacology·Michael F HughesKirk T Kitchin
Mar 28, 2007·Analytica Chimica Acta·Michael FrickeJohn Creed
Jul 17, 2007·Chemical Research in Toxicology·Hua NaranmanduraKazuo T Suzuki
Jul 24, 2007·Molecular Cell·Angus C Wilson
Feb 19, 2008·Cellular Signalling·Rebecca S ArkellSimon J Cook
Aug 2, 2008·Toxicology and Applied Pharmacology·Kirk T Kitchin, Kathleen Wallace
Sep 25, 2008·Molecular Aspects of Medicine·Christopher C FranklinTerrance J Kavanagh
Mar 18, 2009·Biochimica Et Biophysica Acta·Regina Brigelius-Flohé, Anna Kipp

❮ Previous
Next ❯

Citations

Jun 1, 2013·Journal of Radiation Research·Tomonori SakuraiJunji Miyakoshi
Jul 23, 2011·Metallomics : Integrated Biometal Science·Na BuHua Naranmandura
Oct 29, 2014·International Journal of Molecular Sciences·Ping WangYumin Lü
Jan 24, 2013·International Journal of Hygiene and Environmental Health·Pritha BhattacharjeeAshok K Giri
Mar 20, 2012·Toxicology and Applied Pharmacology·Hua NaranmanduraNoriyuki Suzuki
Dec 15, 2015·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Hidetoshi KurosawaGinji Endo
Jul 31, 2013·Environmental and Molecular Mutagenesis·Lee E MooreKenneth P Cantor
Dec 20, 2014·Journal of Applied Toxicology : JAT·Fei Zhao, Walter T Klimecki
Jan 7, 2015·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Yasuyo ShimodaGinji Endo
Sep 18, 2013·Critical Reviews in Toxicology·Samuel M CohenMichal Eldan
May 12, 2012·Biochimica Et Biophysica Acta·Agnes W BootsRoel P F Schins
Feb 19, 2014·Regulatory Toxicology and Pharmacology : RTP·P Robinan GentryJanice W Yager
Jun 21, 2016·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Franziska EbertTanja Schwerdtle
Jun 6, 2013·Chemical Research in Toxicology·Baowei ChenX Chris Le
Aug 6, 2011·Chemical Research in Toxicology·Hua NaranmanduraX Chris Le

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.